Wuhan Gxene Biotech Co., Ltd. (Gxene Biotech) is located in the Free Trade Biotech Innovation Hub, the core biotech park within Wuhan High-Tech Zone. Founded by a team of highly educated recombinant protein, antibody and cell engineers with decades of hands-on R&D experience, we are a high-tech enterprise integrating R&D, manufacturing and sales. We specialize in the R&D and production of bioactive recombinant proteins, early-stage antibody discovery, interacting protein identification, and protein & antibody development. Our client base spans life science research, in vitro diagnostics and drug development sectors.

 

 

       Gxene Biotech addresses industry bottlenecks in developing biofunctional proteins and high-quality, high-throughput antibodies. Built upon two core platforms — mammalian cell protein expression platform and B-cell antibody discovery platform — we provide dedicated one-stop technical services for protein expression and antibody development to research institutes, universities, IVD manufacturers and pharmaceutical companies. We operate high-throughput recombinant antibody expression and single-cell antibody discovery platforms that leverage microfluidic sorting and characterization technology for rapid candidate molecule screening. Our phage display antibody discovery platform boasts extensive experience in library construction and biopanning, including fully human antibody libraries and immunized libraries from multiple species. We maintain alpaca and shark nanobody discovery platforms to support bispecific antibody development and cell therapy programs. Additional capabilities include antibody engineering platforms for humanization and affinity maturation, together with a comprehensive pharmacodynamic evaluation platform.

       Our R&D scientists possess decades of experience in protein expression and antibody development with cutting-edge technical know-how and fully equipped facilities. We hold leading expertise in bioactive protein expression, recombinant rabbit monoclonal antibody development, recombinant antibody production and stable cell line generation. We deliver technical services for academic and industrial clients including prokaryotic expression, eukaryotic expression, polyclonal antibody production, monoclonal antibody generation, neutralizing antibody development, therapeutic antibody manufacturing, recombinant antibody production, hybridoma cell culture, antibody labeling and ELISA kit development.

       Over 75% of our clients are located in Europe and North America. Backed by profound technical expertise and extensive seed banks of primers, cDNA, plasmids and hybridoma cells, as well as inventories of diagnostic reagent intermediates, we offer immediate access to approximately 7,000 proteins, 13,000 antibodies and 5,000 assay kits. The protein division consists of four technical platforms: peptide synthesis, small-molecule antigen modification, native protein extraction, and recombinant protein expression with prokaryotic (E. coli) and eukaryotic systems (yeast, baculovirus-insect cell and mammalian cell). The antibody division maintains integrated platforms for polyclonal antibody, monoclonal antibody and cloud-clone antibody production. The formulation platform develops diagnostic kits, mainly ELISA and CLIA kits. Our testing platform performs analysis and QC for all proteins, antibodies and assay kits under a three-tier quality control framework: raw material testing, intermediate testing and finished-product testing.

 

 

       Committed to independent innovation and sustained R&D investment, Wuhan Gxene Biotech has built platforms for flow sorting, hybridoma sequencing, single-cell sequencing, protein structural analysis, recombinant protein & antibody expression and purification, stable cell line generation and screening, multi-dimensional sample QC and multi-application process development, enabling continuous upgrading of our service standards. We continuously refine delivery workflows and service specifications to ensure consistent quality throughout manufacturing and final deliverables. We serve every industrial client with professional technical capability and responsive support.

 

📧
🔗
💬
公众号二维码 Scan with WeChat to follow us.
⬆
×

Online Inquiry